NINLARO

takeda canada inc🇨🇦 Health Canada

Approval Id: 2a1820665bb180c0
Drug Approval Canada Name: NINLARO
Product Name: NINLARO
Status: Marketed
Status Date: 2016-09-21
Original Market Date: 2016-09-21
Din: 02456796
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XG03 IXAZOMIB
Atc Name: l 01 xg 03
Aig Number: 0158410001
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

IXAZOMIB (IXAZOMIB CITRATE)

2.3 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2a1820665bb180c0

Type

Standard